Structure Therapeutics Inc.
Price Action
Technical Summary
CONSOLIDATINGStructure Therapeutics Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 72), indicating performance broadly in line with the market. Earnings growth of 195% provides fundamental context to the price action. Investors should exercise caution due to high volatility (61% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $47.43 | -13.89% | BELOW |
| 50 SMA | $51.72 | -21.04% | BELOW |
| 100 SMA | $63.12 | -35.30% | BELOW |
| 150 SMA | $53.33 | -23.42% | BELOW |
| 200 SMA | $45.02 | -9.28% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GPCR in an uptrend right now?
GPCR has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is GPCR overbought or oversold?
GPCR's RSI (14) is 31. The stock is in neutral territory, neither overbought nor oversold.
Is GPCR outperforming the market?
GPCR has a Relative Strength (RS) Rating of 72 out of 99. GPCR is performing about average compared to the market.
Where is GPCR in its 52-week range?
GPCR is trading at $40.84, which is 43% of its 52-week high ($94.90) and 32% above its 52-week low ($15.80).
How volatile is GPCR?
GPCR has a Beta of 0.96 and 52-week volatility of 61%. It's less volatile than the S&P 500 - generally more stable.